Federal Register #DOD2026OS1222

Department of Defense announces Uniform Formulary Beneficiary Advisory Panel public meeting

This notice announces a public meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) under the Department of Defense (DoD). - Government Buyer: - Department of Defense (DoD) - Office of the Under Secretary of Defense for Personnel and Readiness - Purpose: - Federal Advisory Committee meeting to review and comment on recommendations regarding the Uniform Formulary - Recommendations made by the Department of War Pharmacy and Therapeutics Committee to the Director of the Defense Health Agency - Meeting Details: - Open to the public - Conducted telephonically or via conference call - Agenda includes therapeutic class reviews, newly approved drugs, and utilization management issues - Procurement Information: - No products, services, OEMs, or vendors are mentioned - No purchase quantities, part numbers, or unique procurement requirements - Notable Requirements: - This is an advisory event, not a procurement action

Description

The Department of Defense is announcing a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP). The meeting will review and comment on recommendations made by the Department of War Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting is open to the public and will be held telephonically or via conference call on September 23, 2026, from 10:00 a.m. to 1:00 p.m. Eastern Standard Time. Written statements from interested persons or organizations may be submitted prior to the meeting for consideration.

View original listing